The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmaceutical Development Preclinical CRO Market Research Report 2025
Synopsis
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care. Pharmaceutical companies invest lots of money to research and produce drugs/medicines for patients. Patients and healthcare providers (doctors, nurses, hospitals, nursing homes, clinics, etc.) are all dependent on these companies for the treatment of diseases.
The global Pharmaceutical Development Preclinical CRO market was valued at US$ 11540 million in 2023 and is anticipated to reach US$ 19890 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Development Preclinical CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Development Preclinical CRO.
Report Scope
The Pharmaceutical Development Preclinical CRO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Development Preclinical CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Development Preclinical CRO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology
Segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing
Safety Pharmacology
Others
Segment by Application
Small and Medium Pharmaceutical Company
Large Pharmaceutical Company
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Development Preclinical CRO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care. Pharmaceutical companies invest lots of money to research and produce drugs/medicines for patients. Patients and healthcare providers (doctors, nurses, hospitals, nursing homes, clinics, etc.) are all dependent on these companies for the treatment of diseases.
The global Pharmaceutical Development Preclinical CRO market was valued at US$ 11540 million in 2023 and is anticipated to reach US$ 19890 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Development Preclinical CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Development Preclinical CRO.
Report Scope
The Pharmaceutical Development Preclinical CRO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Development Preclinical CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Development Preclinical CRO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology
Segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing
Safety Pharmacology
Others
Segment by Application
Small and Medium Pharmaceutical Company
Large Pharmaceutical Company
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Development Preclinical CRO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bioanalysis and DMPK Studies
1.2.3 Toxicology Testing
1.2.4 Safety Pharmacology
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical Development Preclinical CRO Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Small and Medium Pharmaceutical Company
1.3.3 Large Pharmaceutical Company
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Development Preclinical CRO Market Perspective (2019-2030)
2.2 Pharmaceutical Development Preclinical CRO Growth Trends by Region
2.2.1 Global Pharmaceutical Development Preclinical CRO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical Development Preclinical CRO Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical Development Preclinical CRO Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical Development Preclinical CRO Market Dynamics
2.3.1 Pharmaceutical Development Preclinical CRO Industry Trends
2.3.2 Pharmaceutical Development Preclinical CRO Market Drivers
2.3.3 Pharmaceutical Development Preclinical CRO Market Challenges
2.3.4 Pharmaceutical Development Preclinical CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Development Preclinical CRO Players by Revenue
3.1.1 Global Top Pharmaceutical Development Preclinical CRO Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical Development Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Development Preclinical CRO Revenue
3.4 Global Pharmaceutical Development Preclinical CRO Market Concentration Ratio
3.4.1 Global Pharmaceutical Development Preclinical CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Development Preclinical CRO Revenue in 2023
3.5 Pharmaceutical Development Preclinical CRO Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Development Preclinical CRO Product Solution and Service
3.7 Date of Enter into Pharmaceutical Development Preclinical CRO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Development Preclinical CRO Breakdown Data by Type
4.1 Global Pharmaceutical Development Preclinical CRO Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical Development Preclinical CRO Breakdown Data by Application
5.1 Global Pharmaceutical Development Preclinical CRO Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical Development Preclinical CRO Market Size (2019-2030)
6.2 North America Pharmaceutical Development Preclinical CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical Development Preclinical CRO Market Size by Country (2019-2024)
6.4 North America Pharmaceutical Development Preclinical CRO Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Development Preclinical CRO Market Size (2019-2030)
7.2 Europe Pharmaceutical Development Preclinical CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Development Preclinical CRO Market Size (2019-2030)
9.2 Latin America Pharmaceutical Development Preclinical CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River Pharmaceutical Development Preclinical CRO Introduction
11.1.4 Charles River Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024)
11.1.5 Charles River Recent Development
11.2 Wuxi AppTec
11.2.1 Wuxi AppTec Company Detail
11.2.2 Wuxi AppTec Business Overview
11.2.3 Wuxi AppTec Pharmaceutical Development Preclinical CRO Introduction
11.2.4 Wuxi AppTec Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024)
11.2.5 Wuxi AppTec Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Detail
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Pharmaceutical Development Preclinical CRO Introduction
11.3.4 Labcorp Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024)
11.3.5 Labcorp Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Detail
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Pharmaceutical Development Preclinical CRO Introduction
11.4.4 Eurofins Scientific Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024)
11.4.5 Eurofins Scientific Recent Development
11.5 PPD, Inc.
11.5.1 PPD, Inc. Company Detail
11.5.2 PPD, Inc. Business Overview
11.5.3 PPD, Inc. Pharmaceutical Development Preclinical CRO Introduction
11.5.4 PPD, Inc. Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024)
11.5.5 PPD, Inc. Recent Development
11.6 ICON Plc.
11.6.1 ICON Plc. Company Detail
11.6.2 ICON Plc. Business Overview
11.6.3 ICON Plc. Pharmaceutical Development Preclinical CRO Introduction
11.6.4 ICON Plc. Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024)
11.6.5 ICON Plc. Recent Development
11.7 Pharmaron
11.7.1 Pharmaron Company Detail
11.7.2 Pharmaron Business Overview
11.7.3 Pharmaron Pharmaceutical Development Preclinical CRO Introduction
11.7.4 Pharmaron Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024)
11.7.5 Pharmaron Recent Development
11.8 Inotiv
11.8.1 Inotiv Company Detail
11.8.2 Inotiv Business Overview
11.8.3 Inotiv Pharmaceutical Development Preclinical CRO Introduction
11.8.4 Inotiv Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024)
11.8.5 Inotiv Recent Development
11.9 ChemPartner
11.9.1 ChemPartner Company Detail
11.9.2 ChemPartner Business Overview
11.9.3 ChemPartner Pharmaceutical Development Preclinical CRO Introduction
11.9.4 ChemPartner Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024)
11.9.5 ChemPartner Recent Development
11.10 JOINN Lab
11.10.1 JOINN Lab Company Detail
11.10.2 JOINN Lab Business Overview
11.10.3 JOINN Lab Pharmaceutical Development Preclinical CRO Introduction
11.10.4 JOINN Lab Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024)
11.10.5 JOINN Lab Recent Development
11.11 EVOTEC
11.11.1 EVOTEC Company Detail
11.11.2 EVOTEC Business Overview
11.11.3 EVOTEC Pharmaceutical Development Preclinical CRO Introduction
11.11.4 EVOTEC Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024)
11.11.5 EVOTEC Recent Development
11.12 Medicilon
11.12.1 Medicilon Company Detail
11.12.2 Medicilon Business Overview
11.12.3 Medicilon Pharmaceutical Development Preclinical CRO Introduction
11.12.4 Medicilon Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024)
11.12.5 Medicilon Recent Development
11.13 Crown Bioscience
11.13.1 Crown Bioscience Company Detail
11.13.2 Crown Bioscience Business Overview
11.13.3 Crown Bioscience Pharmaceutical Development Preclinical CRO Introduction
11.13.4 Crown Bioscience Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024)
11.13.5 Crown Bioscience Recent Development
11.14 Champion Oncology
11.14.1 Champion Oncology Company Detail
11.14.2 Champion Oncology Business Overview
11.14.3 Champion Oncology Pharmaceutical Development Preclinical CRO Introduction
11.14.4 Champion Oncology Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024)
11.14.5 Champion Oncology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Bioanalysis and DMPK Studies
Table 3. Key Players of Toxicology Testing
Table 4. Key Players of Safety Pharmacology
Table 5. Key Players of Others
Table 6. Global Pharmaceutical Development Preclinical CRO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Pharmaceutical Development Preclinical CRO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Pharmaceutical Development Preclinical CRO Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Pharmaceutical Development Preclinical CRO Market Share by Region (2019-2024)
Table 10. Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Pharmaceutical Development Preclinical CRO Market Share by Region (2025-2030)
Table 12. Pharmaceutical Development Preclinical CRO Market Trends
Table 13. Pharmaceutical Development Preclinical CRO Market Drivers
Table 14. Pharmaceutical Development Preclinical CRO Market Challenges
Table 15. Pharmaceutical Development Preclinical CRO Market Restraints
Table 16. Global Pharmaceutical Development Preclinical CRO Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Pharmaceutical Development Preclinical CRO Market Share by Players (2019-2024)
Table 18. Global Top Pharmaceutical Development Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Development Preclinical CRO as of 2023)
Table 19. Ranking of Global Top Pharmaceutical Development Preclinical CRO Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Pharmaceutical Development Preclinical CRO Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pharmaceutical Development Preclinical CRO Product Solution and Service
Table 23. Date of Enter into Pharmaceutical Development Preclinical CRO Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmaceutical Development Preclinical CRO Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Type (2019-2024)
Table 27. Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Type (2025-2030)
Table 29. Global Pharmaceutical Development Preclinical CRO Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Application (2019-2024)
Table 31. Global Pharmaceutical Development Preclinical CRO Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Pharmaceutical Development Preclinical CRO Revenue Market Share by Application (2025-2030)
Table 33. North America Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Pharmaceutical Development Preclinical CRO Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Pharmaceutical Development Preclinical CRO Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Pharmaceutical Development Preclinical CRO Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pharmaceutical Development Preclinical CRO Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size by Country (2025-2030) & (US$ Million)
Table 48. Charles River Company Detail
Table 49. Charles River Business Overview
Table 50. Charles River Pharmaceutical Development Preclinical CRO Product
Table 51. Charles River Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024) & (US$ Million)
Table 52. Charles River Recent Development
Table 53. Wuxi AppTec Company Detail
Table 54. Wuxi AppTec Business Overview
Table 55. Wuxi AppTec Pharmaceutical Development Preclinical CRO Product
Table 56. Wuxi AppTec Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024) & (US$ Million)
Table 57. Wuxi AppTec Recent Development
Table 58. Labcorp Company Detail
Table 59. Labcorp Business Overview
Table 60. Labcorp Pharmaceutical Development Preclinical CRO Product
Table 61. Labcorp Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024) & (US$ Million)
Table 62. Labcorp Recent Development
Table 63. Eurofins Scientific Company Detail
Table 64. Eurofins Scientific Business Overview
Table 65. Eurofins Scientific Pharmaceutical Development Preclinical CRO Product
Table 66. Eurofins Scientific Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024) & (US$ Million)
Table 67. Eurofins Scientific Recent Development
Table 68. PPD, Inc. Company Detail
Table 69. PPD, Inc. Business Overview
Table 70. PPD, Inc. Pharmaceutical Development Preclinical CRO Product
Table 71. PPD, Inc. Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024) & (US$ Million)
Table 72. PPD, Inc. Recent Development
Table 73. ICON Plc. Company Detail
Table 74. ICON Plc. Business Overview
Table 75. ICON Plc. Pharmaceutical Development Preclinical CRO Product
Table 76. ICON Plc. Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024) & (US$ Million)
Table 77. ICON Plc. Recent Development
Table 78. Pharmaron Company Detail
Table 79. Pharmaron Business Overview
Table 80. Pharmaron Pharmaceutical Development Preclinical CRO Product
Table 81. Pharmaron Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024) & (US$ Million)
Table 82. Pharmaron Recent Development
Table 83. Inotiv Company Detail
Table 84. Inotiv Business Overview
Table 85. Inotiv Pharmaceutical Development Preclinical CRO Product
Table 86. Inotiv Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024) & (US$ Million)
Table 87. Inotiv Recent Development
Table 88. ChemPartner Company Detail
Table 89. ChemPartner Business Overview
Table 90. ChemPartner Pharmaceutical Development Preclinical CRO Product
Table 91. ChemPartner Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024) & (US$ Million)
Table 92. ChemPartner Recent Development
Table 93. JOINN Lab Company Detail
Table 94. JOINN Lab Business Overview
Table 95. JOINN Lab Pharmaceutical Development Preclinical CRO Product
Table 96. JOINN Lab Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024) & (US$ Million)
Table 97. JOINN Lab Recent Development
Table 98. EVOTEC Company Detail
Table 99. EVOTEC Business Overview
Table 100. EVOTEC Pharmaceutical Development Preclinical CRO Product
Table 101. EVOTEC Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024) & (US$ Million)
Table 102. EVOTEC Recent Development
Table 103. Medicilon Company Detail
Table 104. Medicilon Business Overview
Table 105. Medicilon Pharmaceutical Development Preclinical CRO Product
Table 106. Medicilon Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024) & (US$ Million)
Table 107. Medicilon Recent Development
Table 108. Crown Bioscience Company Detail
Table 109. Crown Bioscience Business Overview
Table 110. Crown Bioscience Pharmaceutical Development Preclinical CRO Product
Table 111. Crown Bioscience Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024) & (US$ Million)
Table 112. Crown Bioscience Recent Development
Table 113. Champion Oncology Company Detail
Table 114. Champion Oncology Business Overview
Table 115. Champion Oncology Pharmaceutical Development Preclinical CRO Product
Table 116. Champion Oncology Revenue in Pharmaceutical Development Preclinical CRO Business (2019-2024) & (US$ Million)
Table 117. Champion Oncology Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Development Preclinical CRO Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pharmaceutical Development Preclinical CRO Market Share by Type: 2023 VS 2030
Figure 3. Bioanalysis and DMPK Studies Features
Figure 4. Toxicology Testing Features
Figure 5. Safety Pharmacology Features
Figure 6. Others Features
Figure 7. Global Pharmaceutical Development Preclinical CRO Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Pharmaceutical Development Preclinical CRO Market Share by Application: 2023 VS 2030
Figure 9. Small and Medium Pharmaceutical Company Case Studies
Figure 10. Large Pharmaceutical Company Case Studies
Figure 11. Pharmaceutical Development Preclinical CRO Report Years Considered
Figure 12. Global Pharmaceutical Development Preclinical CRO Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Pharmaceutical Development Preclinical CRO Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pharmaceutical Development Preclinical CRO Market Share by Region: 2023 VS 2030
Figure 15. Global Pharmaceutical Development Preclinical CRO Market Share by Players in 2023
Figure 16. Global Top Pharmaceutical Development Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Development Preclinical CRO as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical Development Preclinical CRO Revenue in 2023
Figure 18. North America Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Pharmaceutical Development Preclinical CRO Market Share by Country (2019-2030)
Figure 20. United States Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Pharmaceutical Development Preclinical CRO Market Share by Country (2019-2030)
Figure 24. Germany Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Pharmaceutical Development Preclinical CRO Market Share by Region (2019-2030)
Figure 32. China Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Pharmaceutical Development Preclinical CRO Market Share by Country (2019-2030)
Figure 40. Mexico Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Pharmaceutical Development Preclinical CRO Market Share by Country (2019-2030)
Figure 44. Turkey Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Pharmaceutical Development Preclinical CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Charles River Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2019-2024)
Figure 47. Wuxi AppTec Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2019-2024)
Figure 48. Labcorp Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2019-2024)
Figure 49. Eurofins Scientific Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2019-2024)
Figure 50. PPD, Inc. Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2019-2024)
Figure 51. ICON Plc. Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2019-2024)
Figure 52. Pharmaron Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2019-2024)
Figure 53. Inotiv Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2019-2024)
Figure 54. ChemPartner Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2019-2024)
Figure 55. JOINN Lab Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2019-2024)
Figure 56. EVOTEC Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2019-2024)
Figure 57. Medicilon Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2019-2024)
Figure 58. Crown Bioscience Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2019-2024)
Figure 59. Champion Oncology Revenue Growth Rate in Pharmaceutical Development Preclinical CRO Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
